https://www.veracyte.com/diagnostics/colon-cancer
[6 24 2023] 0261U
AN UPDATE ON THE IMMUNOSCORE COLON CANCER TEST
Dear Customer,
Thank you for your interest in the Immunoscore Colon Cancer test.
Veracyte has made the difficult decision to pause commercial efforts for the test, based on the need to prioritize our focus among the multiple tests in our portfolio. We are continuing to run and report Immunoscore Colon Cancer tests that were ordered through September 7, 2022.
Veracyte remains committed to immuno-oncology. We view this evolving field as a significant opportunity to help advance precision medicine for patients with cancer. To that end, we look forward to continuing to support important research with Immunoscore-based assays that support our biopharma and other partners.
If you have any questions, please contact our customer service team at 804-944-2009.
Sincerely,
The Veracyte Team
Thank you for your interest in the Immunoscore Colon Cancer test.
Veracyte has made the difficult decision to pause commercial efforts for the test, based on the need to prioritize our focus among the multiple tests in our portfolio. We are continuing to run and report Immunoscore Colon Cancer tests that were ordered through September 7, 2022.
Veracyte remains committed to immuno-oncology. We view this evolving field as a significant opportunity to help advance precision medicine for patients with cancer. To that end, we look forward to continuing to support important research with Immunoscore-based assays that support our biopharma and other partners.
If you have any questions, please contact our customer service team at 804-944-2009.
Sincerely,
The Veracyte Team
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.